Abstract: A mirror for an ophthalmic laser treatment device that is movable on an axis from a position in a treatment laser beam path to a position out of the treatment laser beam path. The mirror reflects light from a light source into the eye of a patient. The mirror is biased towards a position in the path and is moved out of the path by an actuator just long enough for the laser treatment to be applied and without noticeable interruption to viewing by a user.

Abstract: A mirror for an ophthalmic laser treatment device that is movable on an axis from a position in a treatment laser beam path to a position out of the treatment laser beam path. The mirror reflects light from a light source into the eye of a patient. The mirror is biased towards a position in the path and is moved out of the path by an actuator just long enough for the laser treatment to be applied and without noticeable interruption to viewing by a user.

Abstract: A mirror for an ophthalmic laser treatment device that is movable on an axis from a position in a treatment laser beam path to a position out of the treatment laser beam path. The mirror reflects light from a light source into the eye of a patient. The mirror is biased towards a position in the path and is moved out of the path by an actuator just long enough for the laser treatment to be applied and without noticeable interruption to viewing by a user.

Abstract: A method of immunotherapy of a mammal or a laser device therefor, includes the step of treating one or more immune privileged cells, tissue or organs of said mammal with a laser to reduce or eliminate the immune privilege status of said one or more cells, tissues and/or organs to thereby elicit an immune response that is beneficial to the mammal. The method of immunotherapy avoids or minimizes lasting damage to the treated cells, tissues and/or organs. The laser treatment is typically, although not exclusively to the pigmented epithelium of the eye or eyes. The method may be for treating a disease or conditions selected from a bacterial infection, a viral infection, early AMD, glaucoma, diabetic retinopathy, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. Typically, the radiant exposure level of the laser treatment is no greater than 60-100% of a visible effect threshold.

Abstract: A method of immunotherapy of a mammal or a laser device therefor, includes the step of treating one or more immune privileged cells, tissue or organs of said mammal with a laser to reduce or eliminate the immune privilege status of said one or more cells, tissues and/or organs to thereby elicit an immune response that is beneficial to the mammal. The method of immunotherapy avoids or minimizes lasting damage to the treated cells, tissues and/or organs. The laser treatment is typically, although not exclusively to the pigmented epithelium of the eye or eyes. The method may be for treating a disease or conditions selected from a bacterial infection, a viral infection, early AMD, glaucoma, diabetic retinopathy, multiple sclerosis, Parkinson's disease, and Alzheimer's disease. Typically, the radiant exposure level of the laser treatment is no greater than 60-100% of a visible effect threshold.

Abstract: An ophthalmic laser system generating a first beam at a wavelength suitable for performing selective laser trabeculoplasty and selectively generating a second beam at a wavelength suitable for performing secondary cataract surgery procedures. The laser system is able to select between directing the first beam or the second beam to the eye of a patient. The first beam is suitably generated at 1064 nm from a Nd:YAG laser and the second beam is frequency doubled to 532 nm in a KTP doubling crystal.

Abstract: An ophthalmic laser system generating a first beam at a wavelength suitable for performing selective laser trabeculoplasty and selectively generating a second beam at a wavelength suitable for performing secondary cataract surgery procedures. The laser system is able to select between directing the first beam or the second beam to the eye of a patient. The first beam is suitably generated at 1064 nm from a Nd:YAG laser and the second beam is frequency doubled to 532 nm in a KTP doubling crystal.

Abstract: A mirror for an ophthalmic laser treatment device that is movable on an axis from a position in a treatment laser beam path to a position out of the treatment laser beam path. The mirror reflects light from a light source into the eye of a patient. The mirror is biased towards a position in the path and is moved out of the path by an actuator just long enough for the laser treatment to be applied and without noticeable interruption to viewing by a user.

Abstract: An ophthalmic laser system generating a first beam at a wavelength suitable for performing selective laser trabeculoplasty and selectively generating a second beam at a wavelength suitable for performing secondary cataract surgery procedures. The laser system is able to select between directing the first beam or the second beam to the eye of a patient. The first beam is suitably generated at 1064 nm from a Nd:YAG laser and the second beam is frequency doubled to 532 nm in a KTP doubling crystal.

Abstract: A method of immunotherapy of a mammal, or a laser device therefor, includes the step of treating one or more immune privileged cells, tissues or organs of said mammal with a laser to reduce or eliminate the immune privilege status of said one or more cells, tissues and/or organs to thereby elicit an immune response that is beneficial to the mammal. The method of immunotherapy avoids or minimizes lasting damage to the treated cells, tissues and/or organs. The laser treatment is typically, although not exclusively, to the pigmented epithelium of the eye or eyes. The method may be for treating a disease or condition selected from: a bacterial infection; a viral infection; early AMD; glaucoma; diabetic retinopathy; multiple sclerosis; Parkinson's disease; and Alzheimer's disease. Typically, the radiant exposure level of the laser treatment is no greater than 60-100% of a visible effect threshold.

Abstract: An ophthalmic laser system generating a first beam at a wavelength suitable for performing selective laser trabeculoplasty and selectively generating a second beam at a wavelength suitable for performing secondary cataract surgery procedures. The laser system is able to select between directing the first beam or the second beam to the eye of a patient. The first beam is suitably generated at 1064 nm from a Nd:YAG laser and the second beam is frequency doubled to 532 nm in a KTP doubling crystal.

Abstract: An ophthalmic laser system generating a first beam at a wavelength suitable for performing selective laser trabeculoplasty and selectively generating a second beam at a wavelength suitable for performing secondary cataract surgery procedures. The laser system is able to select between directing the first beam or the second beam to the eye of a patient. The first beam is suitably generated at 1064 nm from a Nd:YAG laser and the second beam is frequency doubled to 532 nm in a KTP doubling crystal.

Abstract: An ophthalmic laser system generating a first beam at a wavelength suitable for performing selective laser trabeculoplasty and selectively generating a second beam at a wavelength suitable for performing secondary cataract surgery procedures. The laser system is able to select between directing the first beam or the second beam to the eye of a patient. The first beam is suitably generated at 1064 nm from a Nd:YAG laser and the second beam is frequency doubled to 532 nm in a KTP doubling crystal.

Abstract: A method of retinal regeneration which improves retinal function by reversal of the degradation of the transport properties of Bruch's membrane. The method involves irradiation through the cornea of the eye to the retinal pigmented epithelium by a laser pulse or sequence of laser pulses having a pulse duration in the range of 10 ps to 20 ?s and at a wavelength in the range of about 500 nm to 900 nm. The method applies a radiant exposure which results in the damaging or altering of the retinal pigmented epithelium cells in such a manner as to trigger cellular responses which improve the hydraulic conductivity of Bruch's membrane without causing irreversible damage to adjacent retinal structures and layers.

Abstract: A laser treatment device for use in retinal regeneration. The laser treatment device includes a laser module that delivers a pulse or sequence of pulses having a pulse duration in the range of 50 ps to 500 ns, a wavelength in the range 500 nm to 900 nm, and a pulse energy in the range 100 ?J to 10 mJ. The laser treatment device also includes a uniform irradiance module that modifies an output beam profile of the laser module to produce a uniform treatment effect and a beam delivery and viewing module that delivers the laser pulse or pulses to the retina with a radiant exposure in the range of 8 mJ/cm2 to 8000 mJ/cm2 per pulse.

Abstract: A method of immunotherapy of a mammal, or a laser device therefor, includes the step of treating one or more immune privileged cells, tissues or organs of said mammal with a laser to reduce or eliminate the immune privilege status of said one or more cells, tissues and/or organs to thereby elicit an immune response that is beneficial to the mammal. The method of immunotherapy avoids or minimizes lasting damage to the treated cells, tissues and/or organs. The laser treatment is typically, although not exclusively, to the pigmented epithelium of the eye or eyes. The method may be for treating a disease or condition selected from: a bacterial infection; a viral infection; early AMD; glaucoma; diabetic retinopathy; multiple sclerosis; Parkinson's disease; and Alzheimer's disease. Typically, the radiant exposure level of the laser treatment is no greater than 60-100% of a visible effect threshold.

Abstract: A laser treatment device for use in retinal regeneration. The laser treatment device includes a laser module that delivers a pulse or sequence of pulses having a pulse duration in the range of 50 ps to 500 ns, a wavelength in the range 500 nm to 900 nm, and a pulse energy in the range 100 ?J to 10 mJ. The laser treatment device also includes a uniform irradiance module that modifies an output beam profile of the laser module to produce a uniform treatment effect and a beam delivery and viewing module that delivers the laser pulse or pulses to the retina with a radiant exposure in the range of 8 mJ/cm2 to 8000 mJ/cm2 per pulse.

Abstract: A method of retinal regeneration which improves retinal function by reversal of the degradation of the transport properties of Bruch's membrane. The method involves irradiation through the cornea of the eye to the retinal pigmented epithelium by a laser pulse or sequence of laser pulses having a pulse duration in the range of 10 ps to 20 ?s and at a wavelength in the range of about 500 nm to 900 nm. The method applies a radiant exposure which results in the damaging or altering of the retinal pigmented epithelium cells in such a manner as to trigger cellular responses which improve the hydraulic conductivity of Bruch's membrane without causing irreversible damage to adjacent retinal structures and layers.

Abstract: An ophthalmic laser system which produces controlled bursts of laser pulses and incorporates a system control processor that calculates the likely tissue effects and the total treatment time based on selected laser treatment parameters. The system incorporates a graphical user interface that displays the likely tissue effects to the user (ophthalmic surgeon) to assist with selection of optimal treatment parameters. The system and method of operation is particularly useful for procedures such as selective retinal therapy by displaying a therapeutic window in which treatment of target tissue is achieved without damage to surrounding tissue.

Abstract: An ophthalmic laser system (1) for performing procedures such as Retinal Photocoagulation and Laser Trabeculoplasty comprises a delivery module (2) and a console module (3). The console module includes a treatment laser and optical elements for directing output from the treatment laser to an optical fiber (16), which is substantially enclosed within the delivery module. The delivery module includes a slit lamp tower (6), viewing microscope (4) and alignment optics for directing and focusing output from the optical fiber to a patient treatment zone.